From: Furosemide and spironolactone doses and hyponatremia in patients with heart failure
Laboratory findings | Hyponatremic patients (N = 183) | Non-hyponatremic patients (N = 382) | p |
---|---|---|---|
Hemoglobin (median, IQR, g/L) | 127 (112–144) | 132 (116–144) | 0.57 |
Hematocrit (mean ± SD, L/L) | 0.39 ± 0.07 | 0.4 ± 0.07 | 0.11 |
Urea (median, IQR,mmol/L) | 10.5 (7–15.5) | 8.7 (6.3–12.2) | 0.004* |
Serum creatinine (median, IQR, mg/dL) | 1.4 (1.1–1.9) | 1.3 (1–1.7) | 0.20 |
Serum potassium (mean ± SD, mmol/L) | 4.3 ± 0.7 | 4.1 ± 0.6 | 0.001* |
Serum chloride (mean ± SD, mmol/L) | 97.2 ± 5.5 | 101.2 ± 4.4 | < 0.001* |
Cardiac troponin I (median, IQR, ng/ml) | 0.051 (0.020–0.108) | 0.039 (0.018–0.089) | 0.12 |
Total cholesterol (median, IQR, mmol/L) | 3.4 (3.1–4.9) | 4.3 (3.5–5) | 0.57 |
HDL (median, IQR, mmol/L) | 1.3 (0.9–1.8) | 1.3 (1.3–1.8) | 0.71 |
LDL (median, IQR, mmol/L) | 2.4 (1.9–3.2) | 2.5 (1.9–3.1) | 0.92 |
Triglycerides (median, IQR, mmol/L) | 1.8 (1.4–2.5) | 1.8 (1.2–2.4) | 0.44 |
Total bilirubin (median, IQR, μmol/L) | 15.9 (11.0–21.0) | 14.3 (11.2–18.9) | 0.26 |
Direct bilirubin (median, IQR, μmol/L) | 4.0 (2.4–7.0) | 4.0 (2.8–6.0) | 0.68 |
Indirect bilirubin (median, IQR, μmol/L) | 11.0 (8.6–13.9) | 10.2 (8.1–13.1) | 0.08 |
Serum uric acid (median, IQR, μmol/L) | 476 (381–574) | 440 (367–545) | 0.10 |
AST (median, IQR, μmol/L) | 27.0 (19.0–37.0) | 24.0 (19.0–33.0) | 0.12 |
ALT (median, IQR, μmol/L) | 23.0 (15.8–33.0) | 23.0 (17.0–34.3) | 0.68 |
GGT (median, IQR, μmol/L) | 45.0 (25.0–97.0) | 39.0 (23.0–82.0) | 0.16 |